Autophagy and Cancer Dormancy

dc.contributor.author	Akkoc, Yunus
dc.contributor.author	Peker, Nesibe
dc.contributor.author	Akcay, Arzu
dc.contributor.author	Gozuacik, Devrim
dc.date.accessioned	2021-12-21T08:46:42Z
dc.date.available	2021-12-21T08:46:42Z
dc.date.issued	2021
dc.identifier.issn	2234-943X
dc.identifier.uri	https://doi.org/10.3389/fonc.2021.627023
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2075
dc.description.abstract	Metastasis and relapse account for the great majority of cancer-related deaths. Most metastatic lesions are micro metastases that have the capacity to remain in a non-dividing state called dormancy for months or even years. Commonly used anticancer drugs
dc.description.sponsorship	Scientific and Technological Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [216S489]
dc.language.iso	English
dc.publisher	Frontıers Medıa Sa
dc.rights	Green Published, gold
dc.title	Autophagy and Cancer Dormancy
dc.type	Review
dc.relation.journal	Frontıers In Oncology
dc.identifier.volume	11
dc.identifier.doi	10.3389/fonc.2021.627023
dc.relation.volume	11

Files in this item

Files	Size	Format	View
There are no files associated with this item.